Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins

被引:100
作者
Gutierrez-Hoya, Adriana [1 ,2 ]
Soto-Cruz, Isabel [1 ]
机构
[1] Univ Nacl Autonoma Mexico, FES Zaragoza, Mol Oncol Lab, Cell Differentiat & Canc Res Unit, Batalla 5 Mayo S-N, Mexico City 09230, DF, Mexico
[2] CONACYT, Catedra CONACYT, Ave Insurgentes Sur 1582, Mexico City 03940, DF, Mexico
关键词
signal transducer and activator of transcription; STAT inhibitors; signaling pathway; cervical cancer; HPV; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN PROSTATE-CANCER; SIGNAL TRANSDUCER; CELL-DIFFERENTIATION; NEGATIVE REGULATOR; STAT5; CONTRIBUTES; GENE-EXPRESSION; E7; ONCOPROTEIN; TUMOR-GROWTH; ACTIVATION;
D O I
10.3390/cells9102297
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway is associated with the regulation of essential cellular mechanisms, such as proliferation, invasion, survival, inflammation, and immunity. Aberrant JAK/STAT signaling contributes to cancer progression and metastatic development. STAT proteins play an essential role in the development of cervical cancer, and the inhibition of the JAK/STAT pathway may be essential for enhancing tumor cell death. Persistent activation of different STATs is present in a variety of cancers, including cervical cancer, and their overactivation may be associated with a poor prognosis and poor overall survival. The oncoproteins E6 and E7 play a critical role in the progression of cervical cancer and may mediate the activation of the JAK/STAT pathway. Inhibition of STAT proteins appears to show promise for establishing new targets in cancer treatment. The present review summarizes the knowledge about the participation of the different components of the JAK/STAT pathway and the participation of the human papillomavirus (HPV) associated with the process of cellular malignancy.
引用
收藏
页数:22
相关论文
共 175 条
[21]   E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells [J].
Chen, Jiaoe ;
Gong, Chaoju ;
Mao, Huiqin ;
Li, Zhaoyun ;
Fang, Zejun ;
Chen, Qiang ;
Lin, Min ;
Jiang, Xiang ;
Hu, Yanyan ;
Wang, Wei ;
Zhang, Xiaomin ;
Chen, Xianjun ;
Li, Hongzhang .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (02) :567-578
[22]   Signaling pathways in HPV-associated cancers and therapeutic implications [J].
Chen, Jiezhong .
REVIEWS IN MEDICAL VIROLOGY, 2015, 25 :24-53
[23]   The composition and signaling of the IL-35 receptor are unconventional [J].
Collison, Lauren W. ;
Delgoffe, Greg M. ;
Guy, Clifford S. ;
Vignali, Kate M. ;
Chaturvedi, Vandana ;
Fairweather, DeLisa ;
Satoskar, Abhay R. ;
Garcia, K. Christopher ;
Hunter, Christopher A. ;
Drake, Charles G. ;
Murray, Peter J. ;
Vignali, Dario A. A. .
NATURE IMMUNOLOGY, 2012, 13 (03) :290-U115
[24]   Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance? [J].
Damele, Laura ;
Ottonello, Selene ;
Mingari, Maria Cristina ;
Pietra, Gabriella ;
Vitale, Chiara .
CANCERS, 2020, 12 (04)
[25]   Direct interaction of jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation [J].
Danial, NN ;
Losman, JA ;
Lu, TH ;
Yip, N ;
Krishnan, K ;
Krolewski, J ;
Goff, SP ;
Wang, JYJ ;
Rothman, PB .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6795-6804
[26]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[27]   Improved chemosensitivity in cervical cancer to cisplatin: Synergistic activity of mahanine through STAT3 inhibition [J].
Das, Ranjita ;
Bhattacharya, Kaushik ;
Samanta, Suman K. ;
Pal, Bikas C. ;
Mandal, Chitra .
CANCER LETTERS, 2014, 351 (01) :81-90
[28]   Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer [J].
Das, Susobhan ;
Roth, Cherice P. ;
Wasson, Lori M. ;
Vishwanatha, Jarnboor K. .
PROSTATE, 2007, 67 (14) :1550-1564
[29]   Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies [J].
Davis, Joshua S. ;
Ferreira, David ;
Paige, Emma ;
Gedye, Craig ;
Boyle, Michael .
CLINICAL MICROBIOLOGY REVIEWS, 2020, 33 (03) :1-117
[30]   Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study [J].
de Sanjose, Silvia ;
Quint, Wim G. V. ;
Alemany, Laia ;
Geraets, Daan T. ;
Ellen Klaustermeier, Jo ;
Lloveras, Belen ;
Tous, Sara ;
Felix, Ana ;
Eduardo Bravo, Luis ;
Shin, Hai-Rim ;
Vallejos, Carlos S. ;
Alonso de Ruiz, Patricia ;
Lima, Marcus Aurelho ;
Guimera, Nuria ;
Clavero, Omar ;
Alejo, Maria ;
Llombart-Bosch, Antonio ;
Cheng-Yang, Chou ;
Alejandro Tatti, Silvio ;
Kasamatsu, Elena ;
Iljazovic, Ermina ;
Odida, Michael ;
Prado, Rodrigo ;
Seoud, Muhieddine ;
Grce, Magdalena ;
Usubutun, Alp ;
Jain, Asha ;
Hernandez Suarez, Gustavo Adolfo ;
Estuardo Lombardi, Luis ;
Banjo, Aekunbiola ;
Menendez, Clara ;
Javier Domingo, Efren ;
Velasco, Julio ;
Nessa, Ashrafun ;
Chichareon, Saibua C. Bunnag ;
Qiao, You Lin ;
Lerma, Enrique ;
Garland, Suzanne M. ;
Sasagawa, Toshiyuki ;
Ferrera, Annabelle ;
Hammouda, Doudja ;
Mariani, Luciano ;
Pelayo, Adela ;
Steiner, Ivo ;
Oliva, Esther ;
Meijer, Chris J. L. M. ;
Al-Jassar, Waleed Fahad ;
Cruz, Eugenia ;
Wright, Thomas C. ;
Puras, Ana .
LANCET ONCOLOGY, 2010, 11 (11) :1048-1056